
Smith & Nephew plc
SNNNYSEHealthcareMedical - Devices
Previous close
$29.26
+$0.22 · +0.76%
SNN company overview
Regular session · ET · Market data may be delayed.
GoAI snapshot
AI-powered factor overview
GoAI score
Buy
Favorable setup — positive multi-factor alignment
Valuation
88
Deep Value
Momentum
45
Neutral
Sentiment
58
Mixed
Risk resilience
68
Moderate Risk
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
AI-generated, informational only, and not investment advice.
Company profile
Company websiteSmith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom, the United States, and internationally. The company operates in three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. It offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products. The company also provides sports medicine joint repair products comprise instruments, technologies, and implants to perform minimally invasive surgery, as well as treating soft tissue injuries and degenerative conditions of the shoulder, knee, hip, and small joints. In addition, it provides arthroscopic enabling technologies comprising fluid management equipment for surgical access, cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, the company offers advanced wound care products for the treatment and prevention of acute and chronic wounds, leg, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, such as biologics and other bioactive technologies for debridement and dermal repair/regeneration, and regenerative medicine products, including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. It serves the healthcare providers. Smith & Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom.
- Industry
- Medical - Devices
- Sector
- Healthcare
- Headquarters
- GB
- CEO
- Deepak S Nath
- Listed since
- Nov 16, 1999
- Employees
- 18,362
Market position
Day range
Current $29.26
52-week range
Current $29.26
- Open
- $28.775
- Previous close
- $29.04
- Volume
- 790.54K
- 0.56× average
- Average volume
- 1.42M
- Average daily volume
- Market cap
- 12.29B USD
- Beta
- 0.69
- Market reference 1
- 50-day average
- $30.3346
- -3.54% below average
- 200-day average
- $32.2527
- -9.28% below average
Financials
Financial snapshot
Latest / TTMValuation & yield
- Enterprise value
- 16.99B USD
- P/E (TTM)
- 19.2×
- P/B (TTM)
- 2.38×
- P/S (TTM)
- 1.92×
- EV / EBITDA
- 12.72×
- Earnings yield
- 4.40%
- Free cash flow yield
- 5.99%
- Dividend yield
- 2.72%
Profitability & efficiency
- Gross margin
- 68.18%
- Operating margin
- 16.69%
- Net margin
- 10.08%
- Return on equity
- 11.82%
- Return on assets
- 5.98%
- Return on invested capital
- 7.07%
Financial health
- Debt / equity
- 0.73×
- Current ratio
- 2.57×
- Altman Z-score
- 3.88
- Piotroski F-score
- 8 of 9
Financial statements
Margin trends
Profitability as a percentage of reported revenue.
Income trends
Revenue
Operating income
Net income
| Metric (USD) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 6.16B USD | 5.81B USD | 5.55B USD | 5.22B USD | 5.21B USD |
| Cost of goods sold | 1.96B USD | 1.73B USD | 1.65B USD | 1.52B USD | 1.51B USD |
| Gross profit | 4.21B USD | 4.08B USD | 3.9B USD | 3.7B USD | 3.7B USD |
| Research and development | 346M USD | 343M USD | 339M USD | 345M USD | 356M USD |
| Selling, general, and administrative | 3.04B USD | 2.9B USD | 2.83B USD | 2.71B USD | 2.64B USD |
| Operating expenses | 3.41B USD | 3.42B USD | 3.47B USD | 3.25B USD | 3.11B USD |
| Interest income | 28.07M USD | 24.01M USD | 34.13M USD | 13.99M USD | 6M USD |
| Interest expense | 141.33M USD | 150.06M USD | 132.51M USD | 79.95M USD | 79.99M USD |
| Depreciation and amortization | 459M USD | 449M USD | 473M USD | 492M USD | 507M USD |
| Operating income | 794M USD | 657M USD | 425M USD | 450M USD | 593M USD |
| Net income | 625M USD | 412M USD | 263M USD | 223M USD | 524M USD |
Company facts updated Aug 24, 2026.
Earnings
- EPS beat rate
- 55%
- 6 beats, 5 misses, 0 met estimates
- Average EPS surprise
- -2.11%
- 11 comparable reports
- Latest EPS result
- 0.95
- Estimate 0.94 · Beat by 0.75%
EPS: actual versus estimate
Recent quarterly results
Revenue: actual versus estimate
Recent quarterly results
Analyst ratings
Third-party consensus; not a GoAI recommendation.
Analyst price target
Average target
$30.93
5.71% upsideRating distribution
23 ratingsRecent analyst actions
SNN news
Corporate actions
Annual dividends per share
Cash distributions grouped by calendar year; partial years are marked.
$0.762
2025 complete year+1.6% since 2021
$0.75
2,021
$0.75
2,022
$0.75
2,023
$0.75
2,024
$0.762
2,025
Corporate action history
| Action | Ex-dividend date | Details | Record date | Payment date |
|---|---|---|---|---|
DividendUpcoming | Oct 2, 2026 | $0.312Semi-Annual | Oct 2, 2026 | Nov 6, 2026 |
Dividend | Oct 3, 2025 | $0.30Semi-Annual | Oct 3, 2025 | Nov 7, 2025 |
Dividend | Mar 28, 2025 | $0.462Semi-Annual | Mar 28, 2025 | May 28, 2025 |
Dividend | Oct 4, 2024 | $0.288Semi-Annual | Oct 4, 2024 | Nov 8, 2024 |
Dividend | Apr 1, 2024 | $0.462Semi-Annual | Apr 2, 2024 | May 22, 2024 |
Dividend | Oct 5, 2023 | $0.288Semi-Annual | Oct 6, 2023 | Nov 1, 2023 |
Ex-dividend Oct 2, 2026
$0.312
Semi-Annual
Record Oct 2, 2026 · Payment Nov 6, 2026
Ex-dividend Oct 3, 2025
$0.30
Semi-Annual
Record Oct 3, 2025 · Payment Nov 7, 2025
Ex-dividend Mar 28, 2025
$0.462
Semi-Annual
Record Mar 28, 2025 · Payment May 28, 2025
Ex-dividend Oct 4, 2024
$0.288
Semi-Annual
Record Oct 4, 2024 · Payment Nov 8, 2024
Ex-dividend Apr 1, 2024
$0.462
Semi-Annual
Record Apr 2, 2024 · Payment May 22, 2024
Ex-dividend Oct 5, 2023
$0.288
Semi-Annual
Record Oct 6, 2023 · Payment Nov 1, 2023
SNN peers
ETFs holding SNN
Funds reporting this stock among their holdings, ordered by reported position size.
Vanguard Total International Stock ETFVXUS10.84M0.00%646.2B USD0.05%$87.71+0.78%
Vanguard FTSE Emerging Markets ETFVWO10.58M0.01%162.3B USD0.06%$60.45+0.72%
Dimensional - International Core Equity 2 ETFDFIC8.64M0.06%15.43B USD0.22%$39.405+0.83%
Avantis International Equity ETFAVDE7.77M0.04%19.1B USD0.23%$94.26+0.87%
Dimensional World ex U.S. Core Equity 2 ETFDFAX5.26M0.04%12.57B USD0.28%$38.16+0.82%
State Street SPDR S&P Kensho New Economies Composite ETFKOMP2.29M0.08%2.71B USD0.20%$69.24+0.92%
Vanguard FTSE All-World ex-US ETFVEU1.74M0.00%95.9B USD0.04%$85.69+0.82%
Vanguard International High Dividend Yield ETFVYMI869.31K0.00%21.9B USD0.07%$105.25+1.02%
Vanguard Total International Stock ETFVXUS- Market value
- 10.84M
- Weight
- 0.00%
- AUM
- 646.2B USD
- Expense ratio
- 0.05%
- Price / 1D
- $87.71+0.78%
Vanguard FTSE Emerging Markets ETFVWO- Market value
- 10.58M
- Weight
- 0.01%
- AUM
- 162.3B USD
- Expense ratio
- 0.06%
- Price / 1D
- $60.45+0.72%
Dimensional - International Core Equity 2 ETFDFIC- Market value
- 8.64M
- Weight
- 0.06%
- AUM
- 15.43B USD
- Expense ratio
- 0.22%
- Price / 1D
- $39.405+0.83%
Avantis International Equity ETFAVDE- Market value
- 7.77M
- Weight
- 0.04%
- AUM
- 19.1B USD
- Expense ratio
- 0.23%
- Price / 1D
- $94.26+0.87%
Dimensional World ex U.S. Core Equity 2 ETFDFAX- Market value
- 5.26M
- Weight
- 0.04%
- AUM
- 12.57B USD
- Expense ratio
- 0.28%
- Price / 1D
- $38.16+0.82%
State Street SPDR S&P Kensho New Economies Composite ETFKOMP- Market value
- 2.29M
- Weight
- 0.08%
- AUM
- 2.71B USD
- Expense ratio
- 0.20%
- Price / 1D
- $69.24+0.92%
Vanguard FTSE All-World ex-US ETFVEU- Market value
- 1.74M
- Weight
- 0.00%
- AUM
- 95.9B USD
- Expense ratio
- 0.04%
- Price / 1D
- $85.69+0.82%
Vanguard International High Dividend Yield ETFVYMI- Market value
- 869.31K
- Weight
- 0.00%
- AUM
- 21.9B USD
- Expense ratio
- 0.07%
- Price / 1D
- $105.25+1.02%
Continue in GoAI
Research SNNresearch.disclaimer











